Literature DB >> 23403427

Activity of daptomycin with or without 25 percent ethanol compared to combinations of minocycline, EDTA, and 25 percent ethanol against methicillin-resistant Staphylococcus aureus isolates embedded in biofilm.

R Estes1, J Theusch, A Beck, D Pitrak, Kathleen M Mullane.   

Abstract

Central venous catheters commonly develop central line-associated bloodstream infections. In vitro antibiotic lock therapy (ALT) was simulated on 10 methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates imbedded in biofilm-coated silicon disks. Five days of 4-h daily exposures to daptomycin (2.5 mg/ml) in 25% ethanol or minocycline (3 mg/ml) plus 25% ethanol and 30 mg/ml EDTA resulted in significantly greater elimination of MRSA colonization than treatment with minocycline alone.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23403427      PMCID: PMC3623312          DOI: 10.1128/AAC.01129-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

2.  DNA fingerprinting analysis of coagulase negative staphylococci implicated in catheter related bloodstream infections.

Authors:  B M Dobbins; P Kite; A Kindon; M J McMahon; M H Wilcox
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

3.  Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours?

Authors:  I Raad; H A Hanna; A Awad; A Alrahwan; C Bivins; A Khan; D Richardson; J L Umphrey; E Whimbey; G Mansour
Journal:  Infect Control Hosp Epidemiol       Date:  2001-03       Impact factor: 3.254

4.  Daptomycin: a novel agent for Gram-positive infections.

Authors:  F P Tally; M Zeckel; M M Wasilewski; C Carini; C L Berman; G L Drusano; F B Oleson
Journal:  Expert Opin Investig Drugs       Date:  1999-08       Impact factor: 6.206

5.  Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement.

Authors:  I Raad; W Costerton; U Sabharwal; M Sacilowski; E Anaissie; G P Bodey
Journal:  J Infect Dis       Date:  1993-08       Impact factor: 5.226

6.  Comparative In vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens.

Authors:  D R Snydman; N V Jacobus; L A McDermott; J R Lonks; J M Boyce
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

7.  Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.

Authors:  D Pittet; D Tarara; R P Wenzel
Journal:  JAMA       Date:  1994-05-25       Impact factor: 56.272

8.  Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs.

Authors:  H Hanberger; L E Nilsson; R Maller; B Isaksson
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

9.  A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients.

Authors:  Joanne Sanders; Alan Pithie; Peter Ganly; Lois Surgenor; Rachel Wilson; Eileen Merriman; Gail Loudon; Rhonda Judkins; Stephen Chambers
Journal:  J Antimicrob Chemother       Date:  2008-07-11       Impact factor: 5.790

10.  The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters.

Authors:  Nasia Safdar; Dennis G Maki
Journal:  Intensive Care Med       Date:  2003-11-26       Impact factor: 17.440

View more
  5 in total

Review 1.  Ventricular shunt infections: immunopathogenesis and clinical management.

Authors:  Yenis Gutierrez-Murgas; Jessica N Snowden
Journal:  J Neuroimmunol       Date:  2014-08-13       Impact factor: 3.478

Review 2.  Antimicrobial lock therapy in central-line associated bloodstream infections: a systematic review.

Authors:  Matteo Vassallo; Brigitte Dunais; Pierre-Marie Roger
Journal:  Infection       Date:  2015-02-06       Impact factor: 3.553

3.  Pharmacokinetics, Tissue Distribution, and Efficacy of VIO-001 (Meropenem/Piperacillin/Tazobactam) for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia in Immunocompetent Rabbits with Chronic Indwelling Vascular Catheters.

Authors:  Vidmantas Petraitis; Ruta Petraitiene; Povilas Kavaliauskas; Ethan Naing; Andrew Garcia; Christina Sutherland; Aki Yoneda Kau; Nicholas Goldner; Christopher Bulow; David P Nicolau; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2021-08-30       Impact factor: 5.191

Review 4.  Antibiotic lock therapy: review of technique and logistical challenges.

Authors:  Julie Ann Justo; P Brandon Bookstaver
Journal:  Infect Drug Resist       Date:  2014-12-12       Impact factor: 4.003

5.  Streptokinase Treatment Reverses Biofilm-Associated Antibiotic Resistance in Staphylococcus aureus.

Authors:  Nis Pedersen Jørgensen; Natalia Zobek; Cindy Dreier; Jakob Haaber; Hanne Ingmer; Ole Halfdan Larsen; Rikke L Meyer
Journal:  Microorganisms       Date:  2016-09-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.